VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $103,721 | -27.8% | 11,654 | -17.8% | 0.01% | -12.5% |
Q1 2024 | $143,623 | -16.8% | 14,178 | -17.4% | 0.01% | -27.3% |
Q4 2023 | $172,660 | +42.2% | 17,163 | +32.4% | 0.01% | +37.5% |
Q3 2023 | $121,435 | -45.5% | 12,960 | +49.2% | 0.01% | +33.3% |
Q1 2022 | $223,000 | +320.8% | 8,684 | +466.8% | 0.01% | +100.0% |
Q3 2020 | $53,000 | -59.5% | 1,532 | -52.1% | 0.00% | -57.1% |
Q2 2020 | $131,000 | – | 3,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |